Nuveen Asset Management’s Ocular Therapeutix OCUL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
$3.54M Sell
414,104
-88,468
-18% -$756K ﹤0.01% 2138
2024
Q3
$4.37M Buy
502,572
+85,799
+21% +$746K ﹤0.01% 2051
2024
Q2
$2.85M Sell
416,773
-796,672
-66% -$5.45M ﹤0.01% 2210
2024
Q1
$11M Buy
1,213,445
+200,902
+20% +$1.83M ﹤0.01% 1531
2023
Q4
$4.52M Buy
1,012,543
+1,505
+0.1% +$6.71K ﹤0.01% 2039
2023
Q3
$3.17M Buy
1,011,038
+91,436
+10% +$287K ﹤0.01% 2094
2023
Q2
$4.75M Buy
919,602
+726,569
+376% +$3.75M ﹤0.01% 1940
2023
Q1
$1.02M Sell
193,033
-18,127
-9% -$95.5K ﹤0.01% 2608
2022
Q4
$594K Sell
211,160
-46,102
-18% -$130K ﹤0.01% 2837
2022
Q3
$1.07M Sell
257,262
-90,835
-26% -$377K ﹤0.01% 2725
2022
Q2
$1.4M Buy
348,097
+20,278
+6% +$81.5K ﹤0.01% 2622
2022
Q1
$1.67M Sell
327,819
-61,729
-16% -$315K ﹤0.01% 2587
2021
Q4
$2.42M Buy
389,548
+61,028
+19% +$380K ﹤0.01% 2477
2021
Q3
$3.47M Buy
328,520
+67,812
+26% +$715K ﹤0.01% 2413
2021
Q2
$3.7M Buy
260,708
+5,757
+2% +$81.6K ﹤0.01% 2402
2021
Q1
$4.18M Sell
254,951
-345,720
-58% -$5.67M ﹤0.01% 2247
2020
Q4
$12.4M Buy
600,671
+353,949
+143% +$7.33M ﹤0.01% 1551
2020
Q3
$1.88M Buy
246,722
+28,488
+13% +$217K ﹤0.01% 2414
2020
Q2
$1.82M Buy
218,234
+76,485
+54% +$637K ﹤0.01% 2375
2020
Q1
$701K Buy
141,749
+8,261
+6% +$40.9K ﹤0.01% 2651
2019
Q4
$527K Sell
133,488
-58,343
-30% -$230K ﹤0.01% 2896
2019
Q3
$583K Buy
191,831
+65,541
+52% +$199K ﹤0.01% 2892
2019
Q2
$556K Buy
+126,290
New +$556K ﹤0.01% 2959